These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24694666)

  • 1. Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes.
    Yang J; Lernmark Å; Uusitalo UM; Lynch KF; Veijola R; Winkler C; Larsson HE; Rewers M; She JX; Ziegler AG; Simell OG; Hagopian WA; Akolkar B; Krischer JP; Vehik K;
    Int J Obes (Lond); 2014 Dec; 38(12):1491-6. PubMed ID: 24694666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden.
    Carlsson A; Kockum I; Lindblad B; Engleson L; Nilsson A; Forsander G; Karlsson AK; Kernell A; Ludvigsson J; Marcus C; Zachrisson I; Ivarsson SA; Lernmark A;
    Int J Obes (Lond); 2012 May; 36(5):718-24. PubMed ID: 21712811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics.
    Sterner Y; Törn C; Lee HS; Larsson H; Winkler C; McLeod W; Lynch K; Simell O; Ziegler A; Schatz D; Hagopian W; Rewers M; She JX; Krischer JP; Akolkar B; Lernmark A;
    J Perinatol; 2011 Dec; 31(12):764-9. PubMed ID: 21527903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
    Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
    Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
    Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
    Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
    Ferrara-Cook C; Geyer SM; Evans-Molina C; Libman IM; Becker DJ; Gitelman SE; Redondo MJ;
    Diabetes Care; 2020 Mar; 43(3):580-587. PubMed ID: 31937610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
    Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
    JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk.
    Nucci AM; Virtanen SM; Cuthbertson D; Ludvigsson J; Einberg U; Huot C; Castano L; Aschemeier B; Becker DJ; Knip M; Krischer JP;
    Diabetologia; 2021 Apr; 64(4):826-835. PubMed ID: 33474583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study.
    Cerqueiro Bybrant M; Grahnquist L; Örtqvist E; Andersson C; Forsander G; Elding Larsson H; Lernmark Å; Ludvigsson J; Marcus C; Carlsson A; Ivarsson SA
    Autoimmunity; 2018 Aug; 51(5):221-227. PubMed ID: 30444426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
    Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
    J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The environment and the origins of islet autoimmunity and Type 1 diabetes.
    Eringsmark Regnéll S; Lernmark A
    Diabet Med; 2013 Feb; 30(2):155-60. PubMed ID: 23252770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes.
    Lipponen K; Gombos Z; Kiviniemi M; Siljander H; Lempainen J; Hermann R; Veijola R; Simell O; Knip M; Ilonen J
    Diabetes; 2010 Dec; 59(12):3253-6. PubMed ID: 20739684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.